Percutaneous aortic valve implantation retrograde from the femoral artery

被引:698
作者
Webb, JG [1 ]
Chandavimol, M [1 ]
Thompson, CR [1 ]
Ricci, DR [1 ]
Carere, RG [1 ]
Munt, BI [1 ]
Buller, CE [1 ]
Pasupati, S [1 ]
Lichtenstein, S [1 ]
机构
[1] St Pauls Hosp, Div Cardiol & Cardiac Surg, Vancouver, BC V6Z 1Y6, Canada
关键词
aorta; stenosis; catheters; stents; valvuloplasty;
D O I
10.1161/CIRCULATIONAHA.105.582882
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Percutaneous aortic valve implantation by an antegrade transvenous approach has been described but is problematic. Retrograde prosthetic aortic valve implantation via the femoral artery has potential advantages. Percutaneous prosthetic aortic valve implantation via the femoral arterial approach is described and the initial experience reported. Methods and Results - The valve prosthesis is constructed from a stainless steel stent with an attached trileaflet equine pericardial valve and a fabric cuff. After routine aortic balloon valvuloplasty, a 22F or 24F sheath is advanced from the femoral artery to the aorta. A steerable, deflectable catheter facilitates manipulation of the prosthesis around the aortic arch and through the stenotic valve. Rapid ventricular pacing is used to reduce cardiac output while the delivery balloon is inflated to deploy the prosthesis within the annulus. Percutaneous aortic prosthetic valve implantation was attempted in 18 patients (aged 81 +/- 6 years) in whom surgical risk was deemed excessive because of comorbidities. Iliac arterial injury, seen in the first 2 patients, did not recur after improvement in screening and access site management. Implantation was successful in 14 patients. After successful implantation, the aortic valve area increased from 0.6 +/- 0.2 to 1.6 +/- 0.4 cm(2). There were no intraprocedural deaths. At follow-up of 75 +/- 55 days, 16 patients (89%) remained alive. Conclusions - This initial experience suggests that percutaneous transarterial aortic valve implantation is feasible in selected high-risk patients with satisfactory short-term outcomes.
引用
收藏
页码:842 / 850
页数:9
相关论文
共 29 条
  • [21] ONEILL WW, 1991, J AM COLL CARDIOL, V17, P193
  • [22] 3-YEAR OUTCOME AFTER BALLOON AORTIC VALVULOPLASTY - INSIGHTS INTO PROGNOSIS OF VALVULAR AORTIC-STENOSIS
    OTTO, CM
    MICKEL, MC
    KENNEDY, JW
    ALDERMAN, EL
    BASHORE, TM
    BLOCK, PC
    BRINKER, JA
    DIVER, D
    FERGUSON, J
    HOLMES, DR
    LAMBREW, CT
    MCKAY, CR
    PALACIOS, IF
    POWERS, ER
    RAHIMTOOLA, SH
    WEINER, BH
    DAVIS, KB
    [J]. CIRCULATION, 1994, 89 (02) : 642 - 650
  • [23] EVALUATION OF AORTIC-INSUFFICIENCY BY DOPPLER COLOR FLOW MAPPING
    PERRY, GJ
    HELMCKE, F
    NANDA, NC
    BYARD, C
    SOTO, B
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (04) : 952 - 959
  • [24] Percutaneous balloon aortic valvuloplasty: Antegrade transseptal vs. conventional retrograde transarterial approach
    Sakata, Y
    Syed, Z
    Salinger, MH
    Feldman, T
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 64 (03) : 314 - 321
  • [25] Percutaneous transcatheter aortic disc valve prosthesis implantation:: A feasibility study
    Sochman, J
    Peregrin, JH
    Pavcnik, D
    Timmermans, H
    Rösch, J
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2000, 23 (05) : 384 - 388
  • [26] Sundt TM, 2000, CIRCULATION, V102, P70
  • [27] QUANTIFICATION OF AORTIC REGURGITATION UTILIZING CONTINUOUS WAVE DOPPLER ULTRASOUND
    TEAGUE, SM
    HEINSIMER, JA
    ANDERSON, JL
    SUBLETT, K
    OLSON, EG
    VOYLES, WF
    THADANI, U
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (03) : 592 - 599
  • [28] The clinical development of percutaneous heart valve technology: A position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society of Cardiovascular Angiography and Intervention (SCAI)
    Vassiliades, TA
    Block, PC
    Cohn, LH
    Adams, DH
    Borer, JS
    Feldman, T
    Holmes, DR
    Laskey, WK
    Lytle, BW
    Mack, MJ
    Williams, DO
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 65 (01) : 73 - 79
  • [29] Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease
    Webb, JG
    Munt, B
    Makkar, RR
    Naqvi, TZ
    Dang, N
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 63 (01) : 89 - 93